These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
618 related items for PubMed ID: 18671910
1. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? Palumbo B, Siepi D, Sabalich I, Tranfaglia C, Parnetti L. Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910 [Abstract] [Full Text] [Related]
2. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, Wolf S, Otto M, Reulbach U, Kölsch H, Jessen F, Schröder J, Schönknecht P, Hampel H, Peters O, Weimer E, Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM, Wiltfang J. Neurobiol Aging; 2008 Jun; 29(6):812-8. PubMed ID: 17239996 [Abstract] [Full Text] [Related]
3. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P. Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699 [Abstract] [Full Text] [Related]
4. Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice. Parnetti L, Lanari A, Saggese E, Spaccatini C, Gallai V. Neurol Sci; 2003 Oct 15; 24(3):199-200. PubMed ID: 14598086 [Abstract] [Full Text] [Related]
5. Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers. Parnetti L, Lanari A, Silvestrelli G, Saggese E, Reboldi P. Mech Ageing Dev; 2006 Feb 15; 127(2):129-32. PubMed ID: 16274728 [Abstract] [Full Text] [Related]
8. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Hampel H, Teipel SJ, Fuchsberger T, Andreasen N, Wiltfang J, Otto M, Shen Y, Dodel R, Du Y, Farlow M, Möller HJ, Blennow K, Buerger K. Mol Psychiatry; 2004 Jul 15; 9(7):705-10. PubMed ID: 14699432 [Abstract] [Full Text] [Related]
11. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S. J Med Assoc Thai; 2011 Feb 15; 94 Suppl 1():S77-83. PubMed ID: 21721431 [Abstract] [Full Text] [Related]
13. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Dement Geriatr Cogn Disord; 2007 Feb 15; 23(5):316-20. PubMed ID: 17374949 [Abstract] [Full Text] [Related]
17. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H. J Intern Med; 2004 Sep 15; 256(3):205-23. PubMed ID: 15324364 [Abstract] [Full Text] [Related]